Paper35719366
Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
Pei LP and 3 others. Front Genet, 2022. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma. Papers, record 35719366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35719366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20736804 | Receiver operating characteristic curve in diagnostic test assessment. | J Thorac Oncol | 2010 | https://conductscience.org/library/papers/20736804 | PubMed |
| 2 | 18853439 | The Human Protein Atlas--a tool for pathology. | J Pathol | 2008 | https://conductscience.org/library/papers/18853439 | PubMed |
| 3 | 33167799 | Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33167799 | PubMed |
| 4 | 34895070 | Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation. | Bioengineered | 2021 | https://conductscience.org/library/papers/34895070 | PubMed |
| 5 | 31385807 | A conserved Mcm4 motif is required for Mcm2-7 double-hexamer formation and origin DNA unwinding. | Elife | 2019 | https://conductscience.org/library/papers/31385807 | PubMed |
| 6 | 29628498 | Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. | Cell Mol Immunol | 2019 | https://conductscience.org/library/papers/29628498 | PubMed |
| 7 | 30903160 | TISIDB: an integrated repository portal for tumor-immune system interactions. | Bioinformatics | 2019 | https://conductscience.org/library/papers/30903160 | PubMed |
| 8 | 31792085 | Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment. | Int J Gynecol Cancer | 2020 | https://conductscience.org/library/papers/31792085 | PubMed |
| 9 | 34746002 | Association of Myometrial Invasion With Lymphovascular Space Invasion, Lymph Node Metastasis, Recurrence, and Overall Survival in Endometrial Cancer: A Meta-Analysis of 79 Studies With 68,870 Patients. | Front Oncol | 2021 | https://conductscience.org/library/papers/34746002 | PubMed |
| 10 | 34768392 | Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer. | J Clin Med | 2021 | https://conductscience.org/library/papers/34768392 | PubMed |
| 11 | 20054807 | MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. | Histol Histopathol | 2010 | https://conductscience.org/library/papers/20054807 | PubMed |
| 12 | 31476594 | MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis. | Neoplasia | 2019 | https://conductscience.org/library/papers/31476594 | PubMed |
| 13 | 21619611 | Identifier mapping performance for integrating transcriptomics and proteomics experimental results. | BMC Bioinformatics | 2011 | https://conductscience.org/library/papers/21619611 | PubMed |
| 14 | 32341083 | Active Replication Checkpoint Drives Genome Instability in Fission Yeast mcm4 Mutant. | Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32341083 | PubMed |
| 15 | 34022794 | MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer. | Cell Mol Biol Lett | 2021 | https://conductscience.org/library/papers/34022794 | PubMed |
| 16 | 31387239 | Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31387239 | PubMed |
| 17 | 34404366 | Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34404366 | PubMed |
| 18 | 28537669 | E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28537669 | PubMed |
| 19 | 31851045 | Molecular characterization of endometrial cancer and therapeutic implications. | Curr Opin Obstet Gynecol | 2020 | https://conductscience.org/library/papers/31851045 | PubMed |
| 20 | 26854213 | TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis. | Cytokine | 2017 | https://conductscience.org/library/papers/26854213 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42321518 | HJURP upregulation, driven by transcription factor NFYA, promotes endometrial carcinoma progression via regulating RASSF8 ubiquitination. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42321518 | PubMed |
| 42292390 | Recent advances in characterizing the immune microenvironment and biomarkers of endometrial carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292390 | PubMed |
| 41614789 | Integrative Bioinformatics and Experimental Validation Establish CCNB1 as a Potential Biomarker for Diagnosis and Prognosis in Colorectal Cancer. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41614789 | PubMed |
| 41333157 | Integrative Multi-Omics and Functional Characterization Reveal MCM4 as a Key Oncogenic Regulator in Hepatocellular Carcinoma. | Onco Targets Ther | 2025 | https://conductscience.org/library/papers/41333157 | PubMed |
| 41140081 | Role of TPD52 in Endometrial Cancer: Impact on EMT and the PI3K/AKT and ERK/MAPK Signaling. | Protein Pept Lett | 2025 | https://conductscience.org/library/papers/41140081 | PubMed |
| 40959096 | Comprehensive analysis reveals MCM4 as a biomarker for guiding therapies and immunomodulatory role in skin cutaneous melanoma. | J Cancer | 2025 | https://conductscience.org/library/papers/40959096 | PubMed |
| 40564876 | MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40564876 | PubMed |
| 40107353 | Minichromosome maintenance 4 plays a key role in protecting against acute kidney injury by regulating tubular epithelial cells survival and regeneration. | J Adv Res | 2026 | https://conductscience.org/library/papers/40107353 | PubMed |
| 39901144 | Celastrol promotes DNA damage and apoptosis in uterine corpus endometrial carcinoma via promotion of KAT2B-mediated RBPJ acetylation and repression of MCM4 transcription. | Mol Med | 2025 | https://conductscience.org/library/papers/39901144 | PubMed |
| 39673574 | Identification of a distinctive immunogenomic gene signature in stage-matched colorectal cancer. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/39673574 | PubMed |
| 38499612 | Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker. | Sci Rep | 2024 | https://conductscience.org/library/papers/38499612 | PubMed |
| 38305309 | TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification. | Recent Pat Anticancer Drug Discov | 2025 | https://conductscience.org/library/papers/38305309 | PubMed |
| 36072975 | Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning. | J Oncol | 2022 | https://conductscience.org/library/papers/36072975 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35719366
GET https://conductscience.org/api/papers/v1/35719366/references?page=2